Stock Events

Stock Events

Grace Therapeutics (GRCE) Q1 2026 Earnings

12FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.28

-0.15

-0.02

0.11

Details

Expected EPS

-0.28

Actual EPS

-0.14

Surprise EPS

0.14

Surprise Percent

+50%

Description

Grace Therapeutics (GRCE) has reported earnings of -0.14 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.